RedHill Biopharma Announces Presentation of Positive Oral Opag...
- Written by LATEST ASIANET NEWS RELEASES
- Published in Asia Net
TEL AVIV, Israel and RALEIGH, NC, June 21, 2021, /PRNewswire-AsiaNet/-- Positive U.S. Phase 2 safety and efficacy data for opaganib, a leading novel, oral, dual-mechanism drug candidate for moderate-to-severe COVID-19, presented at the World Microbe Forum Opaganib was associated with a reduction in the need for su...
Authors: LATEST ASIANET NEWS RELEASES